APA (7th ed.) Citation

CB, J., DC, B., JB, L., HE, D., R, Z., A, A., . . . A, G. (2023). Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety, 46(2), 157. https://doi.org/10.1007/s40264-022-01263-3

Chicago Style (17th ed.) Citation

CB, Johannes, et al. "Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting." Drug Safety 46, no. 2 (2023): 157. https://doi.org/10.1007/s40264-022-01263-3.

MLA (9th ed.) Citation

CB, Johannes, et al. "Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting." Drug Safety, vol. 46, no. 2, 2023, p. 157, https://doi.org/10.1007/s40264-022-01263-3.